Singapore markets open in 1 hour 20 minutes

Agilent Technologies, Inc. (A)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
138.12+0.61 (+0.44%)
At close: 04:02PM EST
138.51 +0.39 (+0.28%)
After hours: 05:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous close137.51
Open136.38
Bid137.27 x 1000
Ask136.95 x 900
Day's range131.28 - 138.49
52-week range112.47 - 179.57
Volume2,154,550
Avg. volume1,676,514
Market cap41.712B
Beta (5Y monthly)1.00
PE ratio (TTM)35.06
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.84 (0.61%)
Ex-dividend date03 Jan 2022
1y target estN/A
All
News
  • Business Wire

    Agilent Announces the Innovative Seahorse XF Pro Analyzer

    SANTA CLARA, Calif., January 24, 2022--Agilent Technologies Inc. (NYSE: A) today announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools. With enhanced performance, more robust and efficient workflows, and an optimized user experience, the XF Pro enables operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fat

  • Business Wire

    Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation

    SANTA CLARA, Calif., January 13, 2022--Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal year 2022 financial results after the stock market closes on Tuesday, Feb. 22. The company will host a live webcast of its investor conference call in listen-only mode on the same day.

  • Business Wire

    Agilent Presents Thought Leader Award to Professor Jason Kovacic

    SANTA CLARA, Calif., January 10, 2022--Agilent Technologies Inc. (NYSE: A) today announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award. Professor Kovacic is being recognized for his influential research on cardiovascular disease—specifically the pathobiology of vascular diseases, coronary artery disease, fibromuscular dysplasia and spontaneous coronary artery dissection.